Group One Trading’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Group One Trading’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,600	Closed	-$1.31K	–	8201
2022 Q4	$1.31K	Sell	1,600 -5,800	-78%	-$5.72K	﹤0.01%	6769
2022 Q3	$8K	Sell	7,400 -2,600	-26%	-$4.16K	﹤0.01%	6673
2022 Q2	$16K	Buy	10,000 +3,100	+45%	+$6.44K	﹤0.01%	6483
2022 Q1	$20K	Sell	6,900 -4,700	-41%	-$16.5K	﹤0.01%	6765
2021 Q4	$55K	Sell	11,600 -12,500	-52%	-$80.7K	﹤0.01%	6261
2021 Q3	$182K	Sell	24,100 -21,000	-47%	-$134K	﹤0.01%	5275
2021 Q2	$336K	Buy	45,100 +33,900	+303%	+$261K	﹤0.01%	4667
2021 Q1	$87K	Sell	11,200 -12,200	-52%	-$122K	﹤0.01%	5786
2020 Q4	$216K	Buy	+23,400	New	+$203K	﹤0.01%	4002

Group One Trading's SURF Position: Q3 2023 in Review

Group One Trading sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 6,774 shares — an estimated $5.89K sold.

Group One Trading first reported a position in SURF in Q4 2020 and held it in 7 quarters. The position peaked at $125K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Group One Trading reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Group One Trading sold 6,774 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $5.89K.
Group One Trading first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Group One Trading's Surface Oncology, Inc. Common Stock position peaked at $125K in Q4 2020.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.